Wordt geladen...
Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis
BACKGROUND: Pancreatic cancer ranks as the fourth leading cause of cancer-related mortality in the USA. And gemcitabine has been the standard of care for advanced pancreatic cancer. However, a combined use of gemcitabine plus cisplatin (GemCis) has shown promising efficacies in pancreatic cancer pat...
Bewaard in:
| Gepubliceerd in: | World J Surg Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772457/ https://ncbi.nlm.nih.gov/pubmed/26927942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-0813-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|